Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy

Journal of Experimental & Clinical Cancer Research

Qing Fan¹  Shuo Yang¹  Bo Wu¹  Bowen Li¹  Liang Yang¹  Hongyuan Jin¹  Jingang Liu¹  Mingyao Huang¹  Xueqiang Peng¹  Xinyu Li¹  Shibo Wei¹  Hangyu Li¹ 

[1]Department of General Surgery, the Fourth Affiliated Hospital, China Medical University, 110032, Shenyang, China

关键词: Hypoxia;    Tumour;    Glucose;    Metabolic reprogramming;   

DOI  :  10.1186/s13046-020-01698-5

来源: Springer

【 摘 要 】

Molecular oxygen (O2) is a universal electron acceptor that is eventually synthesized into ATP in the mitochondrial respiratory chain of all metazoans. Therefore, hypoxia biology has become an organizational principle of cell evolution, metabolism and pathology. Hypoxia-inducible factor (HIF) mediates tumour cells to produce a series of glucose metabolism adaptations including the regulation of glucose catabolism, glycogen metabolism and the biological oxidation of glucose to hypoxia. Since HIF can regulate the energy metabolism of cancer cells and promote the survival of cancer cells, targeting HIF or HIF mediated metabolic enzymes may become one of the potential treatment methods for cancer. In this review, we summarize the established and recently discovered autonomous molecular mechanisms that can induce cell reprogramming of hypoxic glucose metabolism in tumors and explore opportunities for targeted therapy.

【 授权许可】

CC BY